Last update 23 Jan 2025

KA-34

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Mechanism-
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Osteoarthritis
Inactive Indication
Osteoarthritis, Knee
Originator Organization
The Scripps Research InstituteThe Scripps Research Institute
Active Organization
The Scripps Research InstituteThe Scripps Research Institute
Inactive Organization
California Institute for Biomedical ResearchCalifornia Institute for Biomedical Research
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with KA-34
NCT03133676
/ CompletedPhase 1IIT
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 Administered Via Intra-Articular Injection in Subjects With Osteoarthritis of the Knee
100 Clinical Results associated with KA-34
Login to view more data
100 Translational Medicine associated with KA-34
Login to view more data
100 Patents (Medical) associated with KA-34
Login to view more data
100 Deals associated with KA-34
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPhase 1-
The Scripps Research InstituteThe Scripps Research Institute
-
Osteoarthritis, KneeDiscovery
US
California Institute for Biomedical ResearchCalifornia Institute for Biomedical Research
02 May 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03133676 (CTgov)
Phase 1
Osteoarthritis, Knee
60
placebo
(Placebo (SAD))
aaoqpbzcoq(gxlbvnydbt) = eiswjsbiqn dojtnsrjuu (sjigwzuahf, grxzchcgvb - djgetbyjoq)
View more
-
17 May 2021
(Cohort 1: KA34 50 µg (SAD))
aaoqpbzcoq(gxlbvnydbt) = nkpakcaxfi dojtnsrjuu (sjigwzuahf, glzmymrply - jojfsujewm)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free